Latest Articles
Woman's Doctor: Know the symptoms of endometrial cancer - MSN
Woman's Doctor: Know the symptoms of endometrial cancer MSN
Published: Dec. 3, 2024, 8:37 p.m.
Elagolix with add-back therapy found effective and tolerable for endometriosis pain - Contemporary Obgyn
Elagolix with add-back therapy found effective and tolerable for endometriosis pain Contemporary Obgyn
Published: Dec. 3, 2024, 6:36 p.m.
NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer - OncLive
NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer OncLive
Published: Dec. 3, 2024, 5:11 p.m.
Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award - The Manila Times
Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award The Manila Times
Published: Dec. 3, 2024, 1:13 p.m.
Common condition linked with increased cancer and early death risks - Yahoo News UK
Common condition linked with increased cancer and early death risks Yahoo News UK
Published: Dec. 3, 2024, 1:12 p.m.
Common condition linked with increased cancer and early death risks - Surrey Live
Common condition linked with increased cancer and early death risks Surrey Live
Published: Dec. 3, 2024, 1:12 p.m.
Orange Girl Foundation organises maiden Menstrual Health Conference - Myjoyonline
Orange Girl Foundation organises maiden Menstrual Health Conference Myjoyonline
Published: Dec. 3, 2024, 1:08 p.m.
Aspira Women's Health Secures $2M ARPA-H Grant for AI-Powered Endometriosis Test | AWH Stock News - StockTitan
Aspira Women's Health Secures $2M ARPA-H Grant for AI-Powered Endometriosis Test | AWH Stock News StockTitan
Published: Dec. 3, 2024, 1 p.m.
Condition affecting millions linked with premature death and cancer risks - Express
Condition affecting millions linked with premature death and cancer risks Express
Published: Dec. 3, 2024, 12:58 p.m.
Karyopharm Therapeutics Provides Endometrial Cancer Program Update - Investor Relations | Karyopharm Therapeutics
Karyopharm Therapeutics Provides Endometrial Cancer Program Update Investor Relations | Karyopharm Therapeutics
Published: Dec. 3, 2024, 12:01 p.m.
Link copied to clipboard!